AT7519

Item number	Size	Delivery time	Price
TGM-T6205-5mg	5 mg	7 - 10 business days*	52.00€
TGM-T6205-1mL	1 ml	7 - 10 business days*	55.00€
TGM-T6205-10mg	10 mg	7 - 10 business days*	79.00€
TGM-T6205-25mg	25 mg	7 - 10 business days*	112.00€
TGM-T6205-50mg	50 mg	7 - 10 business days*	167.00€
TGM-T6205-100mg	100 mg	7 - 10 business days*	223.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: AT7519 is a CDK1/2/4/6/9 inhibitor (IC50: 10-210 nM). It is less effective to CDK3... more

Close menu

Product information "AT7519"

Description: AT7519 is a CDK1/2/4/6/9 inhibitor (IC50: 10-210 nM). It is less effective to CDK3 and little active to CDK7. Target: CDK, GSK-3, Apoptosis. Smiles: N(C(=O)C1=C(Cl)C=CC=C1Cl)C=2C(C(NC3CCNCC3)=O)=NNC2. References: Squires MS, et al. Mol Cancer Ther, 2009, 8(2), 324-332.

Supplier:	TargetMol
Supplier-Nr:	T6205

Properties

Application:	ATP competitive CDK inhibitor
MW:	382.24 D
Formula:	C16H17Cl2N5O2

Database Information

CAS :	844442-38-2\| Matching products
KEGG ID :	K02087 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "AT7519"

Write a review